首页 | 本学科首页   官方微博 | 高级检索  
     

曲美他嗪治疗缺血性心脏病合并心力衰竭的疗效分析
引用本文:刘丽,雷萍. 曲美他嗪治疗缺血性心脏病合并心力衰竭的疗效分析[J]. 实用心脑肺血管病杂志, 2011, 19(12): 2039-2040
作者姓名:刘丽  雷萍
作者单位:四川省江油市人民医院内二科,621700
摘    要:目的探讨心肌能量代谢药物曲美他嗪与1,6-二磷酸果糖治疗缺血性心脏病并心力衰竭的临床疗效。方法收集60例缺血性心脏病合并心力衰竭患者,按入组编号随机分为观察组与对照组,每组各30例,在强心、利尿及扩血管等常规治疗基础上,观察组给予曲美他嗪干预治疗,对照组予以1,6-二磷酸果糖治疗,对比两组患者疗效及心功能变化。结果观察组有效率为86.67%,明显优于对照组的76.67%,差异有统计学意义(P〈0.05);两组患者心功能均较前好转,治疗前后左室舒张末径(LVEDD)及左室射血分数(LVEF)比较差异均有统计学意义(P〈0.05),且观察组LVEDD及LVEF改善程度均好于对照组,差异有统计学意义(P〈0.05)。结论心肌能量代谢药物曲美他嗪治疗缺血性心脏病合并心力衰竭疗效显著,且曲美他嗪在提高疗效及改善心功能方面优于1,6-二磷酸果糖,值得临床推广和进一步研究。

关 键 词:心脏病  心力衰竭  曲美他嗪

Trimetazidine Treatment of Ischemic Heart Disease and Heart Failure Analysis
LIU Li,LEI Ping. Trimetazidine Treatment of Ischemic Heart Disease and Heart Failure Analysis[J]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease, 2011, 19(12): 2039-2040
Authors:LIU Li  LEI Ping
Affiliation:.The Second Division of Neurology,Jiangyou People′s Hospital,Jiangyou 621700,China
Abstract:Objective Myocardial energy metabolism of drugs of trimetazidine and 1,6-diphosphate treatment of ischemic heart disease and heart failure clinical efficacy.Methods Collected 60 cases of ischemic heart disease and heart failure patients,according to the number enrolled randomly divided into observation group and the control group,each group with 30 patients in cardiac,diuretic and vasodilator and other conventional treatment based on,the observation group were given trimetazidine triazine intervention and t...
Keywords:Heart disease  Heart failure  Trimetazidine  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号